Back to medical news
MedPage Today
GLP-1s May Be Taking Our Eyes Off the Real Obesity Problem
September 4, 2026
Original source summary
(MedPage Today) -- GLP-1 receptor agonists may be powerful tools for treating obesity and cardiometabolic disease, but relying on medications alone risks overlooking the forces helping drive the obesity epidemic, according to Laura Schmidt, PhD...
Verbatim from MedPage Today's own feed — "GLP-1s May Be Taking Our Eyes Off the Real Obesity Problem"
Want more like this?
Browse more from the feed. A free account unlocks the full feed, saving and communities.
More medical news